NDAINJECTIONINJECTABLEPriority Review
Approved
Mar 1984
Lifecycle
LOE Approaching
Competitive Pressure
60/100
Clinical Trials
2
Data completeness
3/8 — Basic
Priority Review
Drug data last refreshed 23h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DDAVP (desmopressin acetate) is a synthetic vasopressin analog administered via injection that binds to V2 receptors in the kidney's collecting ducts to increase water reabsorption and reduce urine output. It is indicated for nocturia and works by enhancing the body's natural antidiuretic mechanism to concentrate urine and decrease nighttime urination frequency.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (60%) signals defensive commercial strategies and potential for consolidation or transition planning within the brand team.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia
Started Apr 2012
124 enrolled
Nocturia
Desmopressin Acetate 0.2 mg Tablets, Fasting
Started Jul 2003
48 enrolled
Healthy
Career Relevance
Working on DDAVP offers exposure to mature product management in a competitive, generic-threatened space where career growth depends on defensive market strategy, market access negotiation, and transition planning. This role is suitable for professionals seeking to develop expertise in LOE management, payer dynamics, and cost-containment innovation rather than growth-stage launches.
Brand Manager
Worked on DDAVP at Nordic Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.